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Abstract
Hierarchical models such as the bivariate and hierarchical summary receiver operating characteristic
(HSROC) models are recommended for meta-analysis of test accuracy studies. These models are
challenging to fit when there are few studies and/or sparse data (for example zero cells in contingency
tables due to studies reporting 100% sensitivity or specificity); the models may not converge, or give
unreliable parameter estimates. Using simulation, we investigated the performance of seven hierarchical
models incorporating increasing simplifications in scenarios designed to replicate realistic situations for
meta-analysis of test accuracy studies. Performance of the models was assessed in terms of estimability
(percentage of meta-analyses that successfully converged and percentage where the between study
correlation was estimable), bias, mean square error and coverage of the 95% confidence intervals. Our
results indicate that simpler hierarchical models are valid in situations with few studies or sparse data. For
synthesis of sensitivity and specificity, univariate random effects logistic regression models are appropriate
when a bivariate model cannot be fitted. Alternatively, an HSROC model that assumes a symmetric SROC
curve (by excluding the shape parameter) can be used if the HSROC model is the chosen meta-analytic
approach. In the absence of heterogeneity, fixed effect equivalent of the models can be applied.
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1 Introduction
Meta-analysis of test accuracy studies aims to produce reliable evidence about the diagnostic
accuracy of a medical test from multiple studies addressing the same question. The bivariate
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model1 and the hierarchical summary receiver operating characteristic (HSROC) model2 are the two
approaches recommended for meta-analysis when a sensitivity and speciﬁcity pair is available for
each study.3–5 These hierarchical models possess theoretical advantages over simpler methods for
meta-analysis of test accuracy studies but ﬁtting them is not trivial. The models are often ﬁtted using
a frequentist approach that relies on likelihood based methods for the estimation of ﬁve parameters.
Solving the likelihood equations requires an iterative process and in certain circumstances, for
instance when there are few studies and/or sparse data (e.g. zero cells due to perfect sensitivity
and/or speciﬁcity) in a meta-analysis, the models fail to converge or they converge but give
unreliable parameter estimates with one or more missing standard errors. These issues are often
encountered by meta-analysts6 and there is uncertainty about how to proceed with meta-analysis in
such situations.
Academic illustrations of the application of hierarchical methods have typically involved large
meta-analyses.1,2,4,7–13 In contrast, our experience of supporting Cochrane and non-Cochrane
diagnostic test accuracy review authors suggest that small meta-analyses or sparse data often
occur and pose a challenge to these data hungry hierarchical models. Others have also noted the
problem of non-convergence.8,10,14–16 Despite the increasing uptake of these models, a recent survey
has suggested a lack of clarity about recommended methods for meta-analysis and a need for
guidance.16 In this paper, using simulation, we evaluate the performance of hierarchical models
for meta-analysis of diagnostic accuracy studies, and we develop recommendations for their use.
Because sensitivity and speciﬁcity are the test accuracy measures most commonly used in meta-
analyses,17 we consider only methods for synthesis of these measures. Other measures such as
likelihood ratios can be derived from functions of the bivariate or HSROC model parameters.
The outline of this paper is as follows. In section 2 we brieﬂy describe common methods used for
meta-analysis when each study contributes a single 2 x 2 table of the results of an index test cross
classiﬁed with a reference standard. In section 3 we outline two motivating examples where the
bivariate model failed to converge, and we apply simpler forms of the hierarchical models to resolve
this. In section 4 we describe the simulation study and present the results for full and simpliﬁed
hierarchical models. In section 5 we discuss our ﬁndings and conclude with recommendations for
selecting an appropriate meta-analytic approach in practice.
2 Methods for meta-analysis of diagnostic accuracy studies
2.1 Univariate pooling methods
Univariate ﬁxed eﬀect or random eﬀects meta-analytic methods pool sensitivity and speciﬁcity
separately, ignoring any correlation that may exist between the two measures. Fixed eﬀect models
assume homogeneity while random eﬀects models assume variability in test accuracy beyond
sampling error alone by allowing each study to have its own test accuracy, i.e. the model includes
a between study variance component (2). Let Ai and Bi be the logit sensitivity and logit
speciﬁcity, and 2Ai and 
2
Bi their variances for the ith study (i¼ 1, 2, . . . ,N), then the models for
sensitivity and speciﬁcity are speciﬁed as
Ai  N A, 2A
 
, Bi  N B, 2B
  ð1Þ
The simplest and most commonly used random eﬀects method is the DerSimonian and Laird
approach which uses a normal distribution to model within study variability. Logit transformed
sensitivity or speciﬁcity and the within study variance are undeﬁned when there are zero cells. A
continuity correction (typically 0.5) is applied, leading to a downward bias in test accuracy.6
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Therefore, univariate methods that use a binomial distribution to model within study variability are
preferred. However, these logistic models are seldom used in practice probably due to lack of
awareness of the methods or software limitations.
2.2 Summary receiver operating characteristic regression
The summary receiver operating characteristic (SROC) curve approach developed by Moses et al.18
accounts for possible heterogeneity in threshold. It uses a logistic transformation of the true positive
and false positive rates (TPR and FPR) and linear regression to model the relationship between test
accuracy and the proportion test positive (related to threshold). If accuracy does not depend on
threshold, the SROC curve is symmetric and can be described by a constant diagnostic odds ratio
(DOR). The DOR is a single measure of test accuracy deﬁned as the ratio of the odds of positivity in
those who have the target condition relative to the odds of positivity in those without the condition.
Therefore, a test with high TPR and low FPR will have a high DOR. This SROC approach is a ﬁxed
eﬀect method in which variation is attributed solely to threshold eﬀect and sampling error. The
approach has methodological limitations which lead to inaccurate standard errors, thus rendering
formal statistical inference invalid.10,13 Similar to the DerSimonian and Laird approach, zero cell
corrections may be required.
2.3 Hierarchical models
Hierarchical models (also known as mixed or multilevel models) take into account correlation
between sensitivity and speciﬁcity across studies while also allowing for variation in test
performance between studies through the inclusion of random eﬀects. The two main approaches
– the bivariate model and the HSROC model – diﬀer in parameterizations, but the models are
mathematically equivalent when no covariates are included.19 The choice of approach is often
determined by variation in the thresholds reported in the included studies and the focus of
inference – a summary point or a SROC curve.
2.3.1 Bivariate random effects model
van Houwelingen et al.20 proposed a bivariate approach to meta-analysis that was adapted by
Reitsma et al.1 for test accuracy meta-analysis. This bivariate model is a linear mixed model that
enables joint analysis of sensitivity and speciﬁcity and takes the form
Ai
Bi
 
 N A
B
 
,
X
AB
 
with
X
AB
¼ 
2
A AB
AB 
2
B
 !
ð2Þ
The model assumes a bivariate normal distribution with mean A and variance 
2
A for the logit
sensitivities, mean B and variance 
2
B for the logit speciﬁcities and AB the covariance between
Ai and Bi across studies. Instead of the covariance, the model can be parameterized using the
between study correlation, AB. Therefore, the bivariate model without a covariate has the following
ﬁve parameters: A, B, 
2
A, 
2
B and AB (or AB). Chu and coworkers
7,12 have shown that a binomial
likelihood should be used for modelling within study variability (especially when data are sparse) as
follows:
yAi  Binomial nAi, g1 Aið Þ
 
, yBi  Binomial nBi, g1 Bið Þ
  ð3Þ
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where yAi and yBi represent the number of true positives and true negatives, nAi and nBi the number
of diseased and non-diseased subjects and g1 Aið Þ and g1 Bið Þ the sensitivity and speciﬁcity in the
ith study, respectively. The logit link g :ð Þ is commonly used but other link functions can be
applied.12,13 The random eﬀects also follow a bivariate normal distribution in this generalized
linear mixed model. If this bivariate model is simpliﬁed by assuming the covariance or correlation
is zero (i.e. an independent variance–covariance structure), the model reduces to two univariate
random eﬀects logistic regression models (UREMs) for sensitivity and speciﬁcity.
2.3.2 HSROC model
The Rutter and Gatsonis HSROC model represents a general framework for meta-analysis of test
accuracy studies and can be viewed as an extension of the Moses SROC approach in which the TPR
and FPR for each study are modelled directly.21 The HSROC model is a nonlinear generalized
mixed model and takes the form
logit ij
  ¼ i þ idisij exp disij  ð4Þ
where ij is the proportion of test positives, true or false positives depending on disease status.
Disease status is represented by disij which is coded 0.5 for the non-diseased (j¼ 0) and 0.5 for the
diseased group (j¼ 1) in the ith study. The implicit threshold i (threshold parameter or positivity
criteria) and diagnostic accuracy i (accuracy parameter) for each study are modelled as random
eﬀects with independent normal distributions i  N , 2
 
and i  N , 2
 
, respectively. The
model also includes a shape or scale parameter  which enables asymmetry in the SROC curve by
allowing accuracy to vary with implicit threshold. Therefore, the SROC curve is symmetric if  ¼ 0
or asymmetric if  6¼ 0. Each study contributes a single point in ROC space and so the estimation of
 requires information from all studies included in the meta-analysis. Thus  is modelled as a ﬁxed
eﬀect. The HSROC model has the following ﬁve parameters: , , , 2 and 
2
 . The model reduces
to a ﬁxed eﬀect model if 2 ¼ 0 and 2 ¼ 0. Other speciﬁcations for SROC curves based on
functions of the bivariate model have been proposed10,22 but in this paper we focus only on the
more established and commonly used Rutter and Gatsonis model.
3 Motivating examples
3.1 Non-contrast computed tomography for diagnosing appendicitis
Hlibczuk et al.23 reviewed the diagnostic accuracy of non-contrast computed tomography (CT) for
emergency department evaluation of adults with suspected appendicitis. Seven studies, evaluating
1060 patients of whom 389 had appendicitis, were included in the review. The prevalence of
appendicitis in the studies ranged from 20% to 84%, with a median of 39%. The forest plot
(Figure 1) shows between study variation in the sensitivities and speciﬁcities, though speciﬁcity
was perfect (100%) in four studies. The authors attempted to ﬁt the bivariate model in SAS but
the model failed to converge.
3.2 CT for diagnosing scaphoid fractures
Yin et al.24 assessed the diagnostic accuracy of CT for diagnosing suspected scaphoid fractures. Six
studies, evaluating 211 patients of whom 44 had a scaphoid fracture, were included in the review.
The prevalence of scaphoid fractures in the studies ranged from 12% to 38%, with a median of 20%.
Figure 1 shows the estimates of sensitivity and speciﬁcity with almost no between study variation;
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ﬁve of the six studies reported 100% sensitivity while all studies reported 100% speciﬁcities. The
authors pooled sensitivity, speciﬁcity and the DOR using a random eﬀects model (method not
speciﬁed).
3.3 Results from reanalysis of the two example datasets
We reanalyzed the two datasets by ﬁtting univariate, bivariate and HSROC models using the
NLMIXED procedure in the SAS software package (version 9.2; SAS Institute, Cary, NC).
UREMs for sensitivity and speciﬁcity were simultaneously obtained by setting the covariance
parameter in a bivariate generalized linear mixed model equal to zero. This is equivalent to
assuming an independent variance–covariance structure. Additional summary measures such as
likelihood ratios and DORs were produced using the ESTIMATE statement within NLMIXED.
The ESTIMATE statement computes additional estimates as a function of parameter values and
produces standard errors and conﬁdence intervals (CIs) using the delta method. Despite numerous
attempts with diﬀerent starting values and optimization algorithms, the bivariate model failed to
converge for both datasets. In addition, the HSROC model containing all ﬁve parameters failed to
converge for the scaphoid fractures dataset. The models ﬁtted and results obtained for both datasets
are summarised in Table 1. For the appendicitis dataset, the complete HSROC model successfully
converged and produced reliable estimates only when boundary constraints (2 0) were speciﬁed
for 2 and 
2
 ; the boundary constraint for 
2
 was activated (estimation truncated at zero) and the
between study correlation was estimated as þ1. This is due to the maximum likelihood estimator
truncating the between-study covariance matrix on the boundary of its parameter space.15 A
bivariate model with a correlation of þ1 corresponds to an HSROC model with 2 truncated at
zero, and a correlation of 1 corresponds to an HSROC model with 2 truncated at zero.
Since the maximum likelihood estimation problems encountered with the bivariate model are
most likely due to boundary estimation of the variance and/or covariance parameters, we attempted
plotting the proﬁle log likelihood for the covariance parameter (maximized with respect to the other
4 parameters). We were unable to produce a plot for the scaphoid fracture example because the
Figure 1. Forest plot of sensitivity and specificity estimates from studies included in the two motivating examples.
FN: false negative; FP: false positive; TN: true negative; TP: true positive.
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bivariate model failed even with ﬁxed values for the covariance. This is unsurprising since there was
almost no between study variation in sensitivity and speciﬁcity.
Figure 2 shows the proﬁle log likelihood for the covariance parameter for the appendicitis
example. The likelihood is ﬂat with very little change in the proﬁle log likelihood. The maximum
of the proﬁle log likelihood was achieved at a covariance of 0.02 (dashed line). For covariances
above 0.02, the bivariate model failed to converge or was unstable, but values between 0.05 and
0.02 appear to be supported by the data. The dotted line shows the value of the log likelihood for a
covariance of zero, i.e. independence between sensitivity and speciﬁcity. This suggests that UREMs
would be appropriate for pooling sensitivity and speciﬁcity in this example.
The two examples illustrate the problem of model convergence, poor parameter estimation and
the need for simpler models. There were only subtle diﬀerences in summary estimates and 95% CIs
for sensitivity, speciﬁcity and the negative likelihood ratio between models ﬁtted to the appendicitis
dataset. In contrast, clear diﬀerences were observed for the positive likelihood ratio and the DOR.
For the scaphoid fractures dataset, there were diﬀerences in summary estimates and 95% CI for
sensitivity and speciﬁcity from the univariate ﬁxed eﬀect model and the HSROC models with both
ﬁxed accuracy and threshold parameters compared to the other models. These examples show that
results can diﬀer between models, and the diﬀerences may not be negligible. Therefore, the
−24.8
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−24.1
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 lo
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Figure 2. Profile log-likelihood function of the covariance parameter in the bivariate model applied to the
appendicitis example.
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identiﬁcation of simpler meta-analytic methods that give valid answers in situations where complex
models fail is of practical importance.
4 Simulation study
4.1 Simulation methods
We conducted a simulation study to compare the performance of aUREMand theHSROCmodel with
various simpliﬁcations (by removing model parameters). Given the mathematical equivalence of the
HSROC and bivariate models when no covariate is included, there was no need to examine the
performance of both models. We chose the HSROC model because it has greater ﬂexibility for
introducing model parsimony by dropping parameters than the bivariate model.19 Since several
authors7–9,15 have shown that approximate methods for modelling within study variability are biased,
we only investigated methods that use a binomial likelihood. The speciﬁcations for the scenarios were
devised to replicate realistic situations encountered in meta-analysis of diagnostic accuracy studies. We
investigated the eﬀect of these factors: 1) number of studies; 2) magnitude of diagnostic accuracy
(DOR); 3) prevalence of disease; 4) between study variation in accuracy and threshold; and 5)
asymmetry in the SROC curve. We modiﬁed the simulation approach used in a previous study25 to
deﬁne the simulation scenarios and generate the simulated datasets as described below.
4.1.1 Generation of simulated data
To determine diagnostic accuracy, we used the standardised distance between the means 1 and 2
(where 241) of the logistic distributions for non-diseased and diseased, respectively. We selected
the diagnostic threshold, t, as the average of the means of the two distributions, i.e. t ¼ 1 þ 2ð Þ=2.
If the two distributions have diﬀerent standard deviations (1 6¼ 2), sensitivity 6¼ speciﬁcity at t and
the SROC curve has an asymmetric shape. The DOR at t can be calculated as follows:
DOR ¼ exp
ﬃﬃﬃﬃﬃ
2
3
r
2  t
2
 1  t
1
 " #
ð5Þ
The sensitivity and speciﬁcity at t can be obtained using the following:
Sensitivity ¼
exp
ﬃﬃﬃﬃ
2
3
q
2t
2
 	 

1 exp
ﬃﬃﬃﬃ
2
3
q
2t
2
 	 
 ,
Specificity ¼ 1
exp
ﬃﬃﬃﬃ
2
3
q
1t
1
 	 

1þ exp
ﬃﬃﬃﬃ
2
3
q
1t
1
 	 

ð6Þ
When the distributions of test results for the diseased and non-diseased have the same standard
deviation (1 ¼ 2 ¼ ), sensitivity ¼ speciﬁcity at t and the SROC curve has a symmetric shape. For
scenarios where 1 ¼ 2 ¼ , we investigated values of diagnostic accuracy that correspond to the
following:
(1) 2  1ð Þ= ¼ 2 (log DOR¼ 3.63, DOR¼ 38; sensitivity¼ speciﬁcity¼ 0.86);
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(2) 2  1ð Þ= ¼ 3 (log DOR¼ 5.44, DOR¼ 231; sensitivity¼ speciﬁcity¼ 0.94)
For scenarios where 2 ¼ 21, using the same 2 and 1 as in (1) and (2) above, the DOR of 38
reduces to 15 (sensitivity¼ 0.71 and speciﬁcity¼ 0.86) and the DOR of 231 reduces to 59
(sensitivity¼ 0.80 and speciﬁcity¼ 0.94).
We investigated meta-analyses with diﬀerent number of studies (k¼ 5, 10, 20). The size of a study
in each meta-analysis, nj, was randomly sampled from a uniform distribution, U(20,200). We varied
nj between 20 and 200 because diagnostic accuracy studies are often small in size.
17,26 Given an
underlying prevalence p, individuals within each study were randomly classiﬁed as diseased or non-
diseased, and assigned a continuous test result value, x, which was randomly sampled from the
logistic distributions. For each study, we used t to determine the outcome of an individual’s test
result; positive if xij4 t, or negative if xij  t. To create the 2 x 2 table for each study, individuals
were then classiﬁed as true positives, false negatives, false positives or true negatives based on test
result and disease status.
To begin we assumed zero between study variation in both accuracy and threshold. We then
introduced between study variation in diagnostic accuracy by adding a value 	 sampled from a
normal distribution with zero mean and standard deviation 0.31. This value was added to the
diﬀerence in means (2  1) for each study. We introduced between study variation in
diagnostic threshold by also sampling from a normal distribution with the average threshold t
as the mean and standard deviation 0.31. We generated 10,000 independent meta-analysis
datasets for each scenario to enable precise estimation of model performance even if a large
proportion of models fail to converge. If all 10,000 datasets for each scenario successfully
converged, they will give a standard error of 0.0022 for the estimation of 95% CI coverage
probability.27 However if only 1000 datasets converged, the standard error will be 0.0069. The
datasets were created using Stata version 10.1 (Stata-Corp, College Station, TX). Table 2
summarises the diﬀerent scenarios investigated. The meta-analysis dataset for the base scenario
for each DOR contained ﬁve studies with an underlying prevalence of 5% and no heterogeneity
in accuracy or threshold.
4.1.2 Meta-analytic models fitted to each dataset
Throughout the rest of this paper, we refer to an HSROC model that contained all ﬁve
parameters as a complete HSROC model. We ﬁtted the following seven models to each meta-
analysis dataset.
(1) UREM – includes A and 
2
A for the logit sensitivities, and B and 
2
B for the logit speciﬁcities.
Note this is a simpliﬁcation of the bivariate generalized mixed model achieved by setting the
covariance or correlation parameter to zero (see section 2.3.1). For brevity, from here on we will
refer to this model simply as the univariate random eﬀects model.
(2) Complete HSROC model – includes all ﬁve parameters , , , 2 and 
2

(3) Symmetric HSROC model – includes , , 2 and 
2

(4) HSROC model with ﬁxed threshold – includes , ,  and 2
(5) HSROC model with ﬁxed accuracy – includes , ,  and 2
(6) HSROC model with ﬁxed accuracy and threshold – includes ,  and  (allows for asymmetry
in the SROC curve)
(7) Symmetric HSROC model with ﬁxed accuracy and threshold parameters – includes only two
parameters  and 
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As shown by Harbord et al.,19 the ﬁve parameters of the bivariate model can be expressed in terms of
those of the HSROC model as follows:
A ¼ exp  
2
 
þ
2
 
, B ¼  exp 
2
 

2
 
ð7Þ
2A ¼ exp ð Þ 2 þ
1
4
2
 
, 2B ¼ exp ð Þ 2 þ
1
4
2
 
, AB ¼  2 
1
4
2
 
ð8Þ
For the ﬁxed accuracy threshold and symmetric ﬁxed accuracy threshold models, 2 ¼ 0 and 2 ¼ 0.
Thus 2A ¼ 0, 2B ¼ 0 and AB ¼ 0, and both models are equivalent to simultaneously ﬁtting two
univariate ﬁxed eﬀect logistic regression models for sensitivity and speciﬁcity (see results for these
models in Table 1). Henceforth, we refer to them as ﬁxed eﬀect models; the models can be considered
a special case of the random eﬀects models where the variances of the random eﬀects are zero. We
used the SAS NLMIXED procedure to ﬁt each of the seven meta-analytic models because Stata does
not have an inbuilt or user deﬁned command for ﬁtting non-linear generalized mixed models. Note
that because of the mathematical relationship between the bivariate and HSROC model, it is
possible in Stata to obtain estimates for the ﬁve parameters of the HSROC model using functions
of parameters from the bivariate model ﬁtted.19 We computed additional estimates by using the
ESTIMATE statement. We computed the log DOR at the average operating point (summary
sensitivity and speciﬁcity). This log DOR is exactly the same value as  if the SROC curve is
symmetric.
Table 2. Scenarios evaluated in the simulation.a
Scenario Prevalence (%) DOR
Heterogeneity in
accuracy and threshold
Asymmetry in
SROC curve
1–3 5 38 No No
4–6 25 38 No No
7–9 50 38 No No
10–12 5 38 Yes No
13–15 25 38 Yes No
16–18 50 38 Yes No
19–21 5 231 No No
22–24 25 231 No No
25–27 50 231 No No
28–30 5 231 Yes No
31–33 25 231 Yes No
34–36 50 231 Yes No
37–39 5 15 Yes Yes
40–42 25 15 Yes Yes
43–45 50 15 Yes Yes
46–48 5 59 Yes Yes
49–51 25 59 Yes Yes
52–54 50 59 Yes Yes
aEach subset of 3 scenarios corresponds to 5, 10 and 20 studies.
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4.1.3 Facilitating convergence of hierarchical models
To aid convergence, we provided a wide range of starting values for model parameters by specifying
a grid of points for a grid search of starting values. We used a quasi-Newton optimization technique
(the NLMIXED default) because it provides an appropriate balance between computation speed
and stability (SAS Institute Inc. SAS OnlineDoc 9.1.3. Cary, NC, 2004). To prevent estimation of
negative variances and to reduce computational problems, we speciﬁed boundary constraints
(2 0) for the variance parameters in the models. To reduce the number of models that failed to
converge, we reﬁtted models by trying a new set of starting values and/or changing the optimization
technique to a Newton-Raphson technique. To obtain a new set of starting values, we ﬁtted a model
with no random eﬀects and used the new parameter estimates together with the original grid of
points for the variance parameters. Thus for some datasets, we made up to four attempts to ﬁt a
hierarchical model.
4.1.4 Assessment of model convergence and stability
Because a model that meets a convergence criterion may be unstable or have missing standard errors
due to issues with model identiﬁability, we assessed convergence in two stages. First, we checked
whether the convergence criterion was met and also whether the additional estimates deﬁned in the
ESTIMATE statements were produced. Second, because standard errors are computed from the
ﬁnal Hessian matrix, we calculated eigenvalues of the Hessian to detect if there were problems. At a
true minimum, eigenvalues will all be positive, i.e. positive deﬁnite. Therefore, for convergence to be
deemed successful, the model had to meet the convergence criterion, produce additional estimates,
and the Hessian had to be positive deﬁnite.
4.1.5 Assessment of performance of meta-analytic models
We assessed performance of the methods by examining estimates of the following measures of
diagnostic accuracy: log DOR, logit sensitivity and logit speciﬁcity. We assessed estimability as
the percentage of meta-analyses that successfully converged and the percentage where the
between study correlation was not estimated as 1 or þ1. We computed the latter for only the
complete HSROC model. For each scenario, we used only the results from meta-analyses that
successfully converged as deﬁned above to calculate (a) the diﬀerence between the average
parameter estimate and the true parameter value to determine bias; (b) the average standard
error and mean square error (MSE incorporates both bias and variability) to assess model
accuracy; and (c) the coverage of the 95% CIs by computing the percentage of meta-analyses for
which the true parameter value was within the 95% CI.
4.2 Simulation results
Altogether we explored 54 scenarios. We can only show results for the log DOR in this article but
results for logit sensitivity and logit speciﬁcity are brieﬂy mentioned. Because homogeneous
accuracy and threshold are the exception rather than the norm for meta-analysis of test accuracy
studies, to illustrate key ﬁndings, we present results mainly for scenarios with heterogeneity at a
DOR of 231 (sparse data are of interest and zero false positives and/or false negatives are more likely
to occur when diagnostic accuracy is high).
4.2.1 Estimability
Zero cells occurred frequently especially when diagnostic accuracy was high (Table 3). Convergence
rates were higher for the complete HSROC model in scenarios with heterogeneity compared to
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scenarios without heterogeneity. This is likely due to the inclusion of heterogeneity parameters in the
HSROC model that become problematic to estimate when the true heterogeneity is zero.
Convergence increased with increasing number of studies and prevalence, and with decreasing
diagnostic accuracy. Convergence decreased in scenarios with asymmetry in the SROC curve
(data not shown). Across scenarios, non-convergence and problems with model identiﬁability
were more common with the complete HSROC and ﬁxed threshold models compared to the
other hierarchical models (Table 4); the symmetric ﬁxed accuracy threshold model always
converged. The complete HSROC model often poorly estimated the correlation between the logit
transformed sensitivities and speciﬁcities as þ1 or 1 (Table 3); estimation as 1 occurred much
more frequently than þ1. The correlation was more likely to be estimated between 1 and þ1 when
there was heterogeneity in accuracy and threshold, greater prevalence of disease and more studies in
a meta-analysis.
4.2.2 Bias
In the base scenario for a DOR of 231, the symmetric HSROC model gave the least percentage bias
for the DOR (4.32%); bias was highest for the ﬁxed threshold (37.8%) and ﬁxed accuracy (36.2%)
models (Table 4). These rankings were consistent as the number of studies increased. As prevalence
increased, the two ﬁxed eﬀect models became the least biased while the ﬁxed accuracy model
remained the most biased.
Table 3. Convergence and estimability of the complete HSROC model applied to 10,000 datasets in 36 different
scenarios.a
DOR N
Prevalence
(%)
No heterogeneity in accuracy and threshold Heterogeneity in accuracy and threshold
Meta-
analyses
with a zero
cellb (%)
Successful
model fit
(positive
definite) (%)
% ^AB
¼1
% ^AB
¼þ1
% ^AB
6¼1 or
þ1
Meta-
analyses
with a zero
cellb (%)
Successful
model fit
(positive
definite) (%)
% ^AB
¼1
% ^AB
¼þ1
% ^AB
6¼1 or
þ1
38 5 5 48 18 14 2.6 1.8 50 36 21 0.6 14
38 5 25 50 18 15 1.7 1.6 51 54 31 0.2 22
38 5 50 52 18 15 1.4 2.0 53 60 34 0.2 26
38 10 5 60 25 17 3.7 4.4 60 52 21 0.2 31
38 10 25 65 24 18 2.4 3.8 67 77 24 0.0 54
38 10 50 72 25 18 2.6 4.1 73 85 24 0.0 61
38 20 5 75 32 20 5.8 6.4 77 70 20 0.0 50
38 20 25 77 30 20 3.7 6.3 78 93 12 0.0 82
38 20 50 82 28 20 3.1 5.8 84 97 10 0.0 88
231 5 5 96 18 11 5.7 1.4 97 30 18 2.4 10
231 5 25 97 21 14 5.0 1.6 98 43 29 2.1 13
231 5 50 99 21 15 4.7 1.9 99 48 31 2.3 14
231 10 5 99 23 13 7.7 3.0 99 41 21 1.3 19
231 10 25 99 29 17 7.6 4.1 100 62 29 0.9 33
231 10 50 100 29 18 6.7 4.1 100 71 32 0.9 39
231 20 5 100 29 15 9.7 4.8 100 54 20 0.3 34
231 20 25 100 35 20 9.2 6.2 100 80 23 0.2 57
231 20 50 100 35 20 9.2 6.5 100 88 22 0.1 66
^AB: estimated between study correlation; DOR: diagnostic odds ratio; N: number of studies.
aAll results are presented as percentages and are based on 10,000 meta-analysis datasets.
bThe percentage of meta-analyses out of 10,000 where at least one study included a zero cell.
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When heterogeneity was introduced, each of the seven models produced the largest bias for the
DOR at the lowest prevalence, though the univariate random eﬀects model gave the least biased
DOR. For all models, bias decreased as prevalence and the number of studies increased. However,
the decrease in bias resulted in a change from overestimation to underestimation for the two ﬁxed
eﬀect models. For bias in the estimates of sensitivity, we observed results similar to those of the
DOR, but the relationship with prevalence was reversed for bias in the estimates of speciﬁcity (data
not shown). Bias in speciﬁcity was very small compared to that of the DOR or sensitivity. For the
three measures, in scenarios with heterogeneity and asymmetry in the SROC curve, bias was lower
than in the corresponding symmetric model.
4.2.3 Model accuracy
A MSE of zero indicates that the model estimated the parameter of interest with perfect accuracy, i.e.
no bias and no variability in the estimation. The MSE of the DOR was highest for the symmetric ﬁxed
accuracy threshold model (40.7) but lowest for the symmetric HSROCmodel (4.26) in the base scenario
(Table 4). At higher prevalence, the two ﬁxed eﬀect models had the lowest MSE. For all models, the
MSE of the DOR decreased as the number of studies and prevalence increased. When heterogeneity
was introduced, the univariate random eﬀects model had the lowest MSE at 5% prevalence but the
symmetric HSROC model had slightly lower MSE than the univariate random eﬀects model at higher
values of prevalence. As the number of studies and prevalence increased, the MSE for all models
decreased and became almost identical except for those of the two ﬁxed eﬀect models. Results for
sensitivity were similar to those for the DOR. The MSE for speciﬁcity was generally very low and
increased slightly with increasing prevalence. For the asymmetric SROC curve scenarios, the ﬁndings
for the three measures were similar to those of the corresponding symmetric scenarios.
4.2.4 Coverage
For a DOR of 231, the symmetric HSROC models gave the best coverage of the 95% CIs for
estimation of the DOR (95.5%) in the base scenario. With the exception of the symmetric ﬁxed
accuracy threshold model, all models were conservative as shown by coverage greater than 95%.
The coverage of 88% for the symmetric ﬁxed accuracy threshold model implied over-conﬁdence in
the estimates but coverage increased as prevalence or the number of studies increased. In contrast,
introduction of heterogeneity led to very poor coverage for the two ﬁxed eﬀect models with coverage
becoming lower as prevalence increased. The univariate random eﬀects model and symmetric
HSROC model often showed good coverage, although the latter tended to show under-coverage
as prevalence increased. For sensitivity, the results were comparable to those of the DOR. Across all
models, coverage was low for speciﬁcity when there was heterogeneity unlike scenarios without
heterogeneity. The asymmetric SROC curve scenarios produced similar results to the symmetric
SROC curve scenarios.
4.2.5 Summary of simulation results and application to motivating examples
The following key points were observed:
. Hierarchical models are more likely to converge if there is heterogeneity in accuracy and
threshold.
. Convergence is also aﬀected by number of studies, prevalence and magnitude of diagnostic
accuracy.
. Correlation between sensitivity and speciﬁcity across studies is often poorly estimated as þ1
or 1.
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. In the absence of heterogeneity, the two ﬁxed eﬀect models were the least biased with low MSE
and good coverage properties for studies with moderate to high prevalence. The symmetric ﬁxed
accuracy threshold model may be of greater utility because it always converged. The symmetric
HSROC model performed better than both ﬁxed eﬀect models when prevalence was low and
there were few studies, but this ﬁnding was based on a convergence rate as low as 13%.
. When heterogeneity was present, the univariate random eﬀects model and the symmetric HSROC
model were often the least biased with low MSE and good coverage (however, there is a risk of
selection bias in these results for scenarios with lower prevalence with smaller numbers of studies
where as few as 34% of simulations converged).
In the simulation, the ﬁxed threshold model often gave biased and imprecise results. However, for
the appendicitis example, the ﬁxed threshold model gave results similar to the complete HSROC
model. The results can be explained by the fact that the estimation of 2 was truncated at zero in the
complete model and so removing 2 from the HSROC model was appropriate in this example unlike
in the simulation scenarios. The results in Table 1 indicate that while the univariate random eﬀects
model and symmetric HSROC model appear to be generally applicable when there is heterogeneity,
other models like the ﬁxed threshold or ﬁxed accuracy can be considered if it is apparent the variance
parameter for threshold or accuracy cannot be estimated.
For the scaphoid fractures example, the results of the simulation indicate that using a univariate
ﬁxed eﬀect model (including the equivalent ﬁxed accuracy threshold and symmetric ﬁxed accuracy
threshold models) was valid because there was no heterogeneity in the speciﬁcities (all six studies
reported 100% speciﬁcity) and very limited heterogeneity in the sensitivities (ﬁve of the studies
reported 100% sensitivity). Even for the ﬁxed eﬀect models, computation of the positive
likelihood ratio and DOR were problematic because of the perfect speciﬁcity.
5 Discussion
In this study we simulated meta-analyses under a number of scenarios and evaluated hierarchical
models for meta-analysis of diagnostic accuracy studies. Our ﬁndings indicate that simplifying
hierarchical models is valid when there are few studies or sparse data. Our recommendations for
selecting alternative models when bivariate or HSROC models fail to converge or converge but give
unreliable estimates, are outlined in Box 1. If estimation of an average operating point (summary
sensitivity and speciﬁcity) is of interest instead of a SROC curve, we recommend a univariate logistic
regression approach with or without random eﬀects depending on the extent to which sensitivity
and/or speciﬁcity vary between studies. These methods are an appropriate alternative for obtaining
independent summaries of sensitivity and speciﬁcity with CIs. However, joint inferences cannot be
made about sensitivity and speciﬁcity through conﬁdence and prediction regions around the average
operating point. These regions account for correlation between sensitivity and speciﬁcity, and are
useful for illustrating uncertainty around the average operating point and the extent of
heterogeneity. If interest lies in the estimation of a SROC curve, the symmetric HSROC model or
its ﬁxed eﬀect equivalent should be considered instead. The symmetric HSROC model is equivalent
to ﬁtting a bivariate model with an exchangeable covariance structure, where the variance of the
random eﬀects for the logit sensitivities is assumed to be the same as that of the logit speciﬁcities. In
extreme situations with no heterogeneity and sparse data, such as the scaphoid fractures example,
even the simplest models may fail to produce usable summary estimates.
Given the poor performance of simpler models like the ﬁxed accuracy and ﬁxed threshold models
in the simulation, we urge meta-analysts to carefully explore their data and visually inspect forest
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plots and SROC plots before undertaking meta-analyses. Such preliminary analyses will provide an
indication of the degree of heterogeneity and the pattern of scatter of the study points in ROC space.
These analyses and the output from unstable or failed models should inform the approach for
simplifying hierarchical models as shown by the appendicitis example. Although more complex
and seldom used in practice, a Bayesian approach is an alternative to the maximum likelihood
approach. In an empirical evaluation, both approaches were found to be similar although
Bayesian methods suggested greater uncertainty (wide credible intervals) around the point
estimates.6
A normal distribution is typically assumed for the random eﬀects in hierarchical meta-analytic
models; violation of this assumption may contribute to non-convergence. Heavy tailed distributions
such as t or Cauchy distributions may be used instead of a normal distribution,2,11 but random
eﬀects are restricted to be normally distributed in SAS NLMIXED and Stata. A Bayesian approach
allows alternative distributions though a normal distribution is often assumed in practice.21 As the
models are often ﬁtted using a maximum likelihood approach, our intention was to oﬀer solutions
Box 1. Recommendations for selecting alternative models when bivariate or HSROC models fail.a
Plot the data
Visual inspection of forest plots and SROC plots may help to identify whether heterogeneity exists.
For example, one may observe complete or near complete lack of variability between estimates of sensitivity
and/or specificity, indicating no heterogeneity in one or both parameters (sensitivity and/or specificity equal
to 100%), or conversely wide variability in observed estimates (e.g. non-overlapping confidence intervals)
indicating large heterogeneity.
Analyses
Select a simpler hierarchical fixed effect or random effects model based on inference of interest (summary
points or SROC curve), observation from the data plot, and previous output from the failed bivariate or
HSROC model
Note: when prevalence is very low and the number of studies is very small, there is potential for bias and the
results of the meta-analysis should be interpreted with caution.
Focus of inference
Heterogeneity
Summary point (summary
sensitivity and specificity) SROC curve
Variability in sensitivity and/or
specificity between studies
observed on the plot
Univariate random effects
logistic regression models
Symmetric HSROC model
Minimal or no variability in
sensitivity and/or specificity
between studies observed on
the plot
Univariate fixed effect logistic
regression modelsb
Symmetric fixed accuracy and
threshold model
A symmetric SROC curve can be described using the diagnostic odds ratio (exponent of the value of the
accuracy parameter).
Section 4.1.3 contains suggestions for facilitating convergence of hierarchical models.
aBivariate or HSROC models either failed to converge or converged (i.e. met the convergence criterion) but gave unreliable
estimates (e.g. with no standard errors, or dependent on starting values).
bThe symmetric fixed accuracy threshold model is equivalent to simultaneously fitting two univariate fixed effect logistic regression
models for sensitivity and specificity.
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within the hierarchical framework recommended for meta-analysis, using one of the software
packages that have made meta-analysis of test accuracy studies more accessible to meta-analysts.
A composite likelihood approach (implemented in R using the glmmML package) that oﬀers some
robustness to model misspeciﬁcations was recently proposed.28 Results from the simulation study
where the composite likelihood method and the bivariate generalized mixed model were applied to
data generated from a bivariate t distribution suggested the methods were insensitive to the heavy
tailed distribution under the logit link function. We used only the logit link in our models.
Our simulations and application to motivating examples support and extend empirical evidence
suggesting that univariate methods generate summary results similar to those derived using full
hierarchical methods.4,6,29 Our ﬁndings also agree with a recent simulation study evaluating the
performance of the bivariate model.30 However, our study is more comprehensive including
application to real motivating examples, investigation of a broad array of possible models,
suggestions for improving model convergence and guidance on how to select an appropriate
model. Furthermore, we do not prescribe a limit on the number of studies required to ﬁt a
hierarchical model, rather the merit of applying a particular model should be carefully assessed as
we have illustrated with our examples.
Our study has some limitations. First, we were not able to fully explore the eﬀect of heterogeneity or
varying the threshold. We addressed factors we considered vital, and varied the sample size of studies
in a meta-analysis to reﬂect reality. According to Begg,31 the statistical properties of hierarchical
models are likely to be most vulnerable when the number of studies is small, and also when sample
sizes are highly variable. Second, analyses of the simulated datasets were conducted only in SAS and
convergence rates may diﬀer between software packages because of diﬀerences in obtaining starting
values and model ﬁtting options. Nonetheless, SAS is the software most often used to ﬁt HSROC
models in frequentist analyses and we were able to explore several options for improving convergence.
Third, when comparingmodels, we did not limit analyses to datasets that converged across all models.
Non-convergence occurred more frequently in challenging datasets where poor model
performance (bias, MSE and coverage) can be expected. Therefore, more complex methods with
poor convergence rates may be biased or give imprecise estimates. The performance of simpler
models with better convergence rates should also be aﬀected but if the models give unbiased and
precise estimates, then simpler models are robust and applicable in such situations.
In summary, random eﬀects logistic models should be the default approach for test accuracy
meta-analyses. We recommend UREMs for sensitivity and speciﬁcity if a bivariate model fails, or a
symmetric HSROC model if estimation of a SROC curve is required and the HSROC model fails. If
homogeneity can be assumed, the two models can be further simpliﬁed to their ﬁxed eﬀect
equivalent. However, when prevalence is very low and the number of studies is very small, the
results of any meta-analysis should be interpreted with caution.
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